Evidence That Bank Vole PrP Is a Universal Acceptor for Prions

PLoS Pathogens

Volumn 10, Issue 4, 2014, Pages

  Watts, Joel C ^a,b   Giles, Kurt ^a,b   Patel, Smita ^a   Oehler, Abby ^b   DeArmond, Stephen J ^a,b   Prusiner, Stanley B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BANK VOLE PRION PROTEIN; PRION PROTEIN; PROTEINASE K; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; CHRONIC WASTING DISEASE AGENT; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; IMMUNOBLOTTING; INFECTION SENSITIVITY; MOUSE; MYODES GLAREOLUS; NEUROPATHOLOGY; NONHUMAN; PRION; PROTEIN CONFORMATION; PROTEIN POLYMORPHISM; SEQUENCE ALIGNMENT; VIRUS STRAIN; VIRUS TRANSMISSION; ANIMAL; ARVICOLINAE; BOVINAE; BRAIN; GENETICS; GUINEA PIG; HAMSTER; HUMAN; METABOLISM; PATHOLOGY; SHEEP; TRANSGENIC MOUSE;

ANIMALS; ARVICOLINAE; BRAIN; CATTLE; CREUTZFELDT-JAKOB SYNDROME; CRICETINAE; ENCEPHALOPATHY, BOVINE SPONGIFORM; GUINEA PIGS; HUMANS; MICE; MICE, TRANSGENIC; PRPSC PROTEINS; SHEEP;

EID: 84901360852     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003990     Document Type: Article

References (84)

1. Watts JC, Balachandran A, Westaway D, (2006) The expanding universe of prion diseases. PLoS Pathog 2: e26.
2. Colby DW, Prusiner SB, (2011) Prions. Cold Spring Harb Perspect Biol 3: a006833.
3. Aguzzi A, Rajendran L, (2009) The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 64: 783-790.
4. Prusiner SB, (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144.
5. Prusiner SB, (1998) Prions. Proc Natl Acad Sci USA 95: 13363-13383.
6. McKinley MP, Bolton DC, Prusiner SB, (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35: 57-62.
7. DeArmond SJ, Sánchez H, Yehiely F, Qiu Y, Ninchak-Casey A, et al. (1997) Selective neuronal targeting in prion disease. Neuron 19: 1337-1348.
8. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, et al. (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46: 224-233.
9. Bessen RA, Marsh RF, (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68: 7859-7868.
10. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, et al. (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274: 2079-2082.
11. Dickinson AG (1976) Scrapie in sheep and goats. In: Kimberlin RH, editor. Slow Virus Diseases of Animals and Man. Amsterdam: North-Holland Publishing Company. pp. 209-241.
12. Tateishi J, Kitamoto T, Hoque MZ, Furukawa H, (1996) Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Neurology 46: 532-537.
13. Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, et al. (2002) A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 34: 921-932.
14. Pattison IH (1965) Experiments with scrapie with special reference to the nature of the agent and the pathology of the disease. In: Gajdusek DC, Gibbs CJ, Jr., Alpers MP, editors. Slow, Latent and Temperate Virus Infections, NINDB Monograph 2. Washington, D.C.: U.S. Government Printing. pp. 249-257.
15. Scott M, Foster D, Mirenda C, Serban D, Coufal F, et al. (1989) Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59: 847-857.
16. Prusiner SB, Scott M, Foster D, Pan K-M, Groth D, et al. (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63: 673-686.
17. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, et al. (1995) Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83: 79-90.
18. Asante EA, Linehan JM, Desbruslais M, Joiner S, Gowland I, et al. (2002) BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 21: 6358-6366.
19. Scott MR, Will R, Ironside J, Nguyen H-OB, Tremblay P, et al. (1999) Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA 96: 15137-15142.
20. Scott MR, Peretz D, Nguyen H-OB, DeArmond SJ, Prusiner SB, (2005) Transmission barriers for bovine, ovine, and human prions in transgenic mice. J Virol 79: 5259-5271.
21. Giles K, Glidden DV, Patel S, Korth C, Groth D, et al. (2010) Human prion strain selection in transgenic mice. Ann Neurol 68: 151-161.
22. Collinge J, Clarke AR, (2007) A general model of prion strains and their pathogenicity. Science 318: 930-936.
23. Chandler RL, Turfrey BA, (1972) Inoculation of voles, Chinese hamsters, gerbils and guinea-pigs with scrapie brain material. Res Vet Sci 13: 219-224.
24. Nonno R, Di Bari MA, Cardone F, Vaccari G, Fazzi P, et al. (2006) Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles. PLoS Pathog 2: e12.
25. Agrimi U, Nonno R, Dell'Omo G, Di Bari MA, Conte M, et al. (2008) Prion protein amino acid determinants of differential susceptibility and molecular feature of prion strains in mice and voles. PLoS Pathog 4: e1000113.
26. Di Bari MA, Chianini F, Vaccari G, Esposito E, Conte M, et al. (2008) The bank vole (Myodes glareolus) as a sensitive bioassay for sheep scrapie. J Gen Virol 89: 2975-2885.
27. Di Bari MA, Nonno R, Castilla J, D'Agostino C, Pirisinu L, et al. (2013) Chronic wasting disease in bank voles: characterisation of the shortest incubation time model for prion diseases. PLoS Pathog 9: e1003219.
28. Cosseddu GM, Nonno R, Vaccari G, Bucalossi C, Fernandez-Borges N, et al. (2011) Ultra-efficient PrPSc amplification highlights potentialities and pitfalls of PMCA technology. PLoS Pathog 7: e1002370.
29. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, et al. (1997) Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci USA 94: 10069-10074.
30. Deleault NR, Lucassen RW, Supattapone S, (2003) RNA molecules stimulate prion protein conversion. Nature 425: 717-720.
31. Caughey B, Baron GS, (2006) Prions and their partners in crime. Nature 443: 803-810.
32. Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, et al. (2012) Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci USA 109: 8546-8551.
33. Watts JC, Giles K, Stöhr J, Oehler A, Bhardwaj S, et al. (2012) Spontaneous generation of rapidly transmissible prions in transgenic mice expressing wild-type bank vole prion protein. Proc Natl Acad Sci USA 109: 3498-3503.
34. Christen B, Perez DR, Hornemann S, Wüthrich K, (2008) NMR structure of the bank vole prion protein at 20 degrees C contains a structured loop of residues 165-171. J Mol Biol 383: 306-312.
35. Cartoni C, Schinina ME, Maras B, Nonno R, Vaccari G, et al. (2005) Identification of the pathological prion protein allotypes in scrapie-infected heterozygous bank voles (Clethrionomys glareolus) by high-performance liquid chromatography-mass spectrometry. J Chromatogr A 1081: 122-126.
36. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347: 921-925.
37. Crozet C, Bencsik A, Flamant F, Lezmi S, Samarut J, et al. (2001) Florid plaques in ovine PrP transgenic mice infected with an experimental ovine BSE. EMBO Rep 2: 952-956.
38. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, et al. (1997) Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389: 498-501.
39. Tamgüney G, Giles K, Bouzamondo-Bernstein E, Bosque PJ, Miller MW, et al. (2006) Transmission of elk and deer prions to transgenic mice. J Virol 80: 9104-9114.
40. Peretz D, Scott M, Groth D, Williamson A, Burton D, et al. (2001) Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 10: 854-863.
41. Wemheuer WM, Benestad SL, Wrede A, Schulze-Sturm U, Wemheuer WE, et al. (2009) Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types. Am J Pathol 175: 2566-2573.
42. Hill AF, Joiner S, Linehan J, Desbruslais M, Lantos PL, et al. (2000) Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci USA 97: 10248-10253.
43. Kobayashi A, Sakuma N, Matsuura Y, Mohri S, Aguzzi A, et al. (2010) Experimental verification of a traceback phenomenon in prion infection. J Virol 84: 3230-3238.
44. Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C, (2010) Darwinian evolution of prions in cell culture. Science 327: 869-872.
45. Korth C, Kaneko K, Groth D, Heye N, Telling G, et al. (2003) Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci USA 100: 4784-4789.
46. Bishop MT, Will RG, Manson JC, (2010) Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 107: 12005-12010.
47. Giles K, De Nicola GF, Patel S, Glidden DV, Korth C, et al. (2012) Identification of I137M and other mutations that modulate incubation periods for two human prion strains. J Virol 86: 6033-6041.
48. Legname G, Nguyen H-OB, Peretz D, Cohen FE, DeArmond SJ, et al. (2006) Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA 103: 19105-19110.
49. Bett C, Kurt TD, Lucero M, Trejo M, Rozemuller AJ, et al. (2013) Defining the conformational features of anchorless, poorly neuroinvasive prions. PLoS Pathog 9: e1003280.
50. Ayers JI, Schutt CR, Shikiya RA, Aguzzi A, Kincaid AE, et al. (2011) The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease. PLoS Pathog 7: e1001317.
51. Colby DW, Giles K, Legname G, Wille H, Baskakov IV, et al. (2009) Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci USA 106: 20417-20422.
52. Ghaemmaghami S, Watts JC, Nguyen H-O, Hayashi S, DeArmond SJ, et al. (2011) Conformational transformation and selection of synthetic prion strains. J Mol Biol 413: 527-542.
53. Kimberlin RH, Hall SM, Walker CA, (1983) Pathogenesis of mouse scrapie: evidence for direct neural spread of infection to the CNS after injection of sciatic nerve. J Neurol Sci 61: 315-325.
54. Kimberlin RH, Walker CA, (1986) Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J Gen Virol 67: 255-263.
55. Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, et al. (2005) Diagnosis of human prion disease. Proc Natl Acad Sci USA 102: 3501-3506.
56. Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J, (2011) Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470: 540-542.
57. Gibbs CJ Jr, Gajdusek DC, (1973) Experimental subacute spongiform virus encephalopathies in primates and other laboratory animals. Science 182: 67-68.
58. Raymond GJ, Raymond LD, Meade-White KD, Hughson AG, Favara C, et al. (2007) Transmission and adaptation of chronic wasting disease to hamsters and transgenic mice: evidence for strains. J Virol 81: 4305-4314.
59. Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, et al. (2009) Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem 284: 22590-22600.
60. Watts JC, Huo H, Bai Y, Ehsani S, Jeon AH, et al. (2009) Interactome analyses identify ties of PrP and its mammalian paralogs to oligomannosidic N-glycans and endoplasmic reticulum-derived chaperones. PLoS Pathog 5: e1000608.
61. Taylor DR, Whitehouse IJ, Hooper NM, (2009) Glypican-1 mediates both prion protein lipid raft association and disease isoform formation. PLoS Pathog 5: e1000666.
62. Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, et al. (2009) De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci USA 106: 304-309.
63. Sigurdson CJ, Joshi-Barr S, Bett C, Winson O, Manco G, et al. (2011) Spongiform encephalopathy in transgenic mice expressing a point mutation in the beta2-alpha2 loop of the prion protein. J Neurosci 31: 13840-13847.
64. Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Fernandez-Borges N, et al. (2010) A molecular switch controls interspecies prion disease transmission in mice. J Clin Invest 120: 2590-2599.
65. Bett C, Fernandez-Borges N, Kurt TD, Lucero M, Nilsson KP, et al. (2012) Structure of the beta2-alpha2 loop and interspecies prion transmission. FASEB J 26: 2868-2876.
66. Hornemann S, Glockshuber R, (1998) A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. Proc Natl Acad Sci USA 95: 6010-6014.
67. Kuwata K, Li H, Yamada H, Legname G, Prusiner SB, et al. (2002) Locally disordered conformer of the hamster prion protein: a crucial intermediate to PrPSc? Biochemistry 41: 12277-12283.
68. Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, et al. (2005) Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 4: 805-814.
69. Cali I, Castellani R, Alshekhlee A, Cohen Y, Blevins J, et al. (2009) Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132: 2643-2658.
70. Angers RC, Kang HE, Napier D, Browning S, Seward T, et al. (2010) Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science 328: 1154-1158.
71. Kimberlin RH, Walker CA, (1985) Competition between strains of scrapie depends on the blocking agent being infectious. Intervirology 23: 74-81.
72. Bartz JC, Kramer ML, Sheehan MH, Hutter JA, Ayers JI, et al. (2007) Prion interference is due to a reduction in strain-specific PrPSc levels. J Virol 81: 689-697.
73. Weissmann C, Li J, Mahal SP, Browning S, (2012) Prions on the move. EMBO Rep 12: 1109-1117.
74. Jucker M, Walker LC, (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501: 45-51.
75. Prusiner SB, (2012) A unifying role for prions in neurodegenerative diseases. Science 336: 1511-1513.
76. Büeler H, Fisher M, Lang Y, Bluethmann H, Lipp H-P, et al. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577-582.
77. Berry DB, Lu D, Geva M, Watts JC, Bhardwaj S, et al. (2013) Drug resistance confounding prion therapeutics. Proc Natl Acad Sci USA 110: E4160-E4169.
78. Carlson GA, Ebeling C, Yang S-L, Telling G, Torchia M, et al. (1994) Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc Natl Acad Sci USA 91: 5690-5694.
79. Watts JC, Stöhr J, Bhardwaj S, Wille H, Oehler A, et al. (2011) Protease-resistant prions selectively decrease shadoo protein. PLoS Pathog 7: e1002382.
80. Safar JG, Giles K, Lessard P, Letessier F, Patel S, et al. (2011) Conserved properties of human and bovine prion strains on transmission to guinea pigs. Lab Invest 91: 1326-1336.
81. Carlson GA, Goodman PA, Lovett M, Taylor BA, Marshall ST, et al. (1988) Genetics and polymorphism of the mouse prion gene complex: control of scrapie incubation time. Mol Cell Biol 8: 5528-5540.
82. Safar JG, Scott M, Monaghan J, Deering C, Didorenko S, et al. (2002) Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 20: 1147-1150.
83. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, et al. (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61: 3688-3693.
84. Williamson RA, Peretz D, Pinilla C, Ball H, Bastidas RB, et al. (1998) Mapping the prion protein using recombinant antibodies. J Virol 72: 9413-9418.